The Patent Finder

Neurocentria, Inc.

19 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Magceutics, Inc. (to 2016)

13
Ending by 2030
Mar 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 8, 2027
    The maintenance fee for Magnesium threonate compositions and uses thereof (US 11,717,501) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
  • 1 fee due Mar 8, 2027
    The maintenance fee for Magnesium compositions and uses thereof for neurological disorders (US 9,125,878) comes due Mar 8, 2027. Unpaid by Sep 8, 2027, it lapses early.
  • 1 fee due Jun 3, 2027
    The maintenance fee for Threonate Compounds and Methods of Use Thereof (US 10,493,048) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
  • 1 fee due Oct 14, 2027
    The maintenance fee for Methods of modifying neuronal function by changing intracellular magnesium levels (US 10,617,713) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,470,352Magnesium compositions and uses thereof for metabolic disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,637,061Magnesium compositions and uses thereof for neurological disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,125,878Magnesium compositions and uses thereof for neurological disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,616,038Magnesium compositions and uses thereof for neurological disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,737,563Magnesium compositions and uses thereof for neurological disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,757,414Magnesium compositions and uses thereof for neurological disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,142,803Magnesium compositions and uses thereof for neurological disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,178,132Magnesium-containing food compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,178,133Magnesium compositions and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,178,118Magnesium compositions and uses thereof for cognitive function
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 7 abandoned · 5 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited